Compound information
- Natural Products
- ZC1416660
- Molecular Formula
- C17H26N2O4S
- Molecular Weight
- 354.161328312 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-[4-[(1S)-1-methylpropyl]phenyl]sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H26N2O4S/c1-4-14(3)15-6-8-16(9-7-15)24(21,22)19-12-10-18(11-13-19)17(20)23-5-2/h6-9,14H,4-5,10-13H2,1-3H3/t14-/m0/s1
- InChI Key
- SCBIEHQFFHLZDZ-AWEZNQCLSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc([C@@H](C)CC)cc2)CC1
- Source
- ZINC000054363075
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.373 |
LogS | -4.261 | LogD | 3.135 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.068 | Pgp substrate | 0.858 |
HIA | 0.974 | F20 % | 0.988 |
F30 % | 0.893 | Caco-2 | -4.394 |
MDCK | -4.806 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.555 | PPB | 91.717 |
VD | 0.985 | Fu | 0.898 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.021 | CYP1A2 substrate | 0.527 |
CYP2A6 substrate | 0.642 | CYP2B6 substrate | 0.677 |
CYP2C19 inhibitor | 0.719 | CYP2C19 substrate | 0.9 |
CYP2C8 substrate | 0.693 | CYP2C9 inhibitor | 0.928 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.07 |
CYP2D6 substrate | 0.944 | CYP2E1 substrate | 0.462 |
CYP3A4 inhibitor | 0.253 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.327 | CL | 6.501 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.228 | Hepatotoxicity | 0.623 |
Mutagenicity | 0.052 | Rat Oral Acute Toxicity | 0.38 |
FDAMDD | 0.252 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.867 | Eye Corrosion | 0.003 |
Eye Irritation | 0.01 | Respiratory Toxicity | 0.565 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.691 | IGC50 | 3.157 |
LC50FM | 3.021 | LC50DM | 2.504 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.279 | NR-AR-LBD | 0.338 |
NR-AhR | 0.052 | NR-Aromatase | 0.3 |
NR-ER | 0.276 | NR-ER-LBD | 0.401 |
NR-PPAR-gamma | 0.141 | SR-ARE | 0.608 |
SR-ATAD5 | 0.315 | SR-HSE | 0.088 |
SR-MMP | 0.024 | SR-p53 | 0.024 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.